Literature DB >> 23164549

Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsylvania and the University of Washington.

G Stennis Watson1, Brenna A Cholerton, Rachel G Gross, Daniel Weintraub, Cyrus P Zabetian, John Q Trojanowski, Thomas J Montine, Andrew Siderowf, James B Leverenz.   

Abstract

Cognitive impairment (CI) and behavioral disturbances can be the earliest symptoms of Parkinson's disease (PD), ultimately afflict the vast majority of PD patients, and increase caregiver burden. Our two Morris K. Udall Centers of Excellence for Parkinson's Disease Research were supported by the National Institute of Neurological Disorders and Stroke (NINDS) in an effort to recommend a comprehensive yet practical approach to cognitive and behavioral assessment to further collaborative research. We recommend a stepwise approach with two levels of standardized evaluation to establish a common battery, as well as an alternative testing recommendation for severely impaired subjects, and review supplemental tests that may be useful in specific research settings. Our flexible approach may be applied to studies with varying emphasis on cognition and behavior, does not place undue burden on participants or resources, and has a high degree of compatibility with existing test batteries to promote collaboration. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23164549      PMCID: PMC3612566          DOI: 10.1016/j.jalz.2012.07.006

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  153 in total

1.  The roles of sequencing and verbal working memory in sentence comprehension deficits in Parkinson's disease.

Authors:  Jesse Hochstadt; Hiroko Nakano; Philip Lieberman; Joseph Friedman
Journal:  Brain Lang       Date:  2005-12-05       Impact factor: 2.381

2.  A recommended scale for cognitive screening in clinical trials of Parkinson's disease.

Authors:  Kelvin L Chou; Melissa M Amick; Jason Brandt; Richard Camicioli; Karen Frei; Darren Gitelman; Jennifer Goldman; John Growdon; Howard I Hurtig; Bonnie Levin; Irene Litvan; Laura Marsh; Tanya Simuni; Alexander I Tröster; Ergun Y Uc
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

3.  Phosphorylated α-synuclein in Parkinson's disease.

Authors:  Yu Wang; Min Shi; Kathryn A Chung; Cyrus P Zabetian; James B Leverenz; Daniela Berg; Karin Srulijes; John Q Trojanowski; Virginia M-Y Lee; Andrew D Siderowf; Howard Hurtig; Irene Litvan; Mya C Schiess; Elaine R Peskind; Masami Masuda; Masato Hasegawa; Xiangmin Lin; Catherine Pan; Douglas Galasko; David S Goldstein; Poul Henning Jensen; Hui Yang; Kevin C Cain; Jing Zhang
Journal:  Sci Transl Med       Date:  2012-02-15       Impact factor: 17.956

4.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

5.  An fMRI study of the Trail Making Test.

Authors:  Konstantine K Zakzanis; Richard Mraz; Simon J Graham
Journal:  Neuropsychologia       Date:  2005-04-22       Impact factor: 3.139

6.  Mental symptoms in Parkinson's disease are important contributors to caregiver distress.

Authors:  D Aarsland; J P Larsen; K Karlsen; N G Lim; E Tandberg
Journal:  Int J Geriatr Psychiatry       Date:  1999-10       Impact factor: 3.485

7.  The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease.

Authors:  David J Gill; Arielle Freshman; Jennifer A Blender; Bernard Ravina
Journal:  Mov Disord       Date:  2008-05-15       Impact factor: 10.338

8.  Enhanced cued recall and clock drawing test performances differ in Parkinson's and Alzheimer's disease-related cognitive dysfunction.

Authors:  Esen Saka; Bülent Elibol
Journal:  Parkinsonism Relat Disord       Date:  2009-05-15       Impact factor: 4.891

9.  Practice effects during repeated administrations of memory tests with and without alternate forms.

Authors:  R H Benedict; D J Zgaljardic
Journal:  J Clin Exp Neuropsychol       Date:  1998-06       Impact factor: 2.475

10.  A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease.

Authors:  Cindy Zadikoff; Susan H Fox; David F Tang-Wai; Teri Thomsen; Rob M A de Bie; Pettarusup Wadia; Janis Miyasaki; Sarah Duff-Canning; Anthony E Lang; Connie Marras
Journal:  Mov Disord       Date:  2008-01-30       Impact factor: 10.338

View more
  15 in total

1.  Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?

Authors:  Rachael Purri; Laura Brennan; Jacqueline Rick; Sharon X Xie; Benjamin L Deck; Lana M Chahine; Nabila Dahodwala; Alice Chen-Plotkin; John E Duda; James F Morley; Rizwan S Akhtar; John Q Trojanowski; Andrew Siderowf; Daniel Weintraub
Journal:  Mov Disord       Date:  2020-06-10       Impact factor: 10.338

Review 2.  Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests.

Authors:  Jeroen Hoogland; Lennard L van Wanrooij; Judith A Boel; Jennifer G Goldman; Glenn T Stebbins; John C Dalrymple-Alford; Connie Marras; Charles H Adler; Carme Junque; Kenn F Pedersen; Brit Mollenhauer; Cyrus P Zabetian; Paul J Eslinger; Simon J G Lewis; Ruey-Meei Wu; Martin Klein; Maria C Rodriguez-Oroz; Davide M Cammisuli; Paolo Barone; Roberta Biundo; Rob M A de Bie; Ben A Schmand; Alexander I Tröster; David J Burn; Irene Litvan; J Vincent Filoteo; Gert J Geurtsen; Daniel Weintraub
Journal:  Mov Disord       Date:  2018-09-14       Impact factor: 10.338

3.  Association of cognitive domains with postural instability/gait disturbance in Parkinson's disease.

Authors:  V E Kelly; C O Johnson; E L McGough; A Shumway-Cook; F B Horak; K A Chung; A J Espay; F J Revilla; J Devoto; C Wood-Siverio; S A Factor; B Cholerton; K L Edwards; A L Peterson; J F Quinn; T J Montine; C P Zabetian; J B Leverenz
Journal:  Parkinsonism Relat Disord       Date:  2015-04-14       Impact factor: 4.891

4.  Cerebral perfusion and cortical thickness indicate cortical involvement in mild Parkinson's disease.

Authors:  Tara M Madhyastha; Mary K Askren; Peter Boord; Jing Zhang; James B Leverenz; Thomas J Grabowski
Journal:  Mov Disord       Date:  2015-03-11       Impact factor: 10.338

5.  Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.

Authors:  David Coughlin; Sharon X Xie; Mendy Liang; Andrew Williams; Claire Peterson; Daniel Weintraub; Corey T McMillan; David A Wolk; Rizwan S Akhtar; Howard I Hurtig; H Branch Coslett; Roy H Hamilton; Andrew D Siderowf; John E Duda; Katya Rascovsky; Edward B Lee; Virginia M-Y Lee; Murray Grossman; John Q Trojanowski; David J Irwin
Journal:  Ann Neurol       Date:  2019-01-07       Impact factor: 10.422

6.  Hallucinations and Development of Dementia in Parkinson's Disease.

Authors:  Wojciech Gryc; Kathryn A Roberts; Cyrus P Zabetian; Daniel Weintraub; John Q Trojanowski; Joseph F Quinn; Amie L Hiller; Kathryn A Chung; Kathleen L Poston; Laurice Yang; Shu-Ching Hu; Karen L Edwards; Thomas J Montine; Brenna A Cholerton
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

7.  Development and Validation of the Parkinson's Disease Medication Beliefs Scale (PD-Rx).

Authors:  Jori E Fleisher; Nabila A Dahodwala; Sharon X Xie; Mark Mayo; Daniel Weintraub; Joshua Chodosh; Judy A Shea
Journal:  J Parkinsons Dis       Date:  2016-04-02       Impact factor: 5.568

8.  Longitudinal study of normal cognition in Parkinson disease.

Authors:  Kara Pigott; Jacqueline Rick; Sharon X Xie; Howard Hurtig; Alice Chen-Plotkin; John E Duda; James F Morley; Lama M Chahine; Nabila Dahodwala; Rizwan S Akhtar; Andrew Siderowf; John Q Trojanowski; Daniel Weintraub
Journal:  Neurology       Date:  2015-09-11       Impact factor: 9.910

9.  Pacific Northwest Udall Center of excellence clinical consortium: study design and baseline cohort characteristics.

Authors:  Brenna A Cholerton; Cyrus P Zabetian; Joseph F Quinn; Kathryn A Chung; Amie Peterson; Alberto J Espay; Fredy J Revilla; Johnna Devoto; G Stennis Watson; Shu-Ching Hu; Karen L Edwards; Thomas J Montine; James B Leverenz
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

Review 10.  Episodic recognition memory and the hippocampus in Parkinson's disease: A review.

Authors:  Tanusree Das; Jaclyn J Hwang; Kathleen L Poston
Journal:  Cortex       Date:  2018-12-04       Impact factor: 4.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.